A 58-Year-Old Man with Biochemically Recurrent Metastatic Castration-Sensitive Prostate Cancer - Episode 2

An Overview of First-line Therapy Options for Patients with mCSPC

A prostate cancer expert shares a brief overview of available first-line therapy options for patients with mCSPC.